Vega

<p>PARSIPPANY, N.J. and TEL AVIV, Israel, June 08, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced new data that highlight the comprehensive tardive dyskinesia (TD) symptom improvement from treatment with AUSTEDO^® and AUSTEDO XR^®. The new findings, drawn from three separate studies, were presented at Psych Congress Elevate, held June 3 – 6, 2026, in Las Vegas, NV.</p>

Jun 8, 2026

<a href="https://news.google.com/rss/articles/CBMiakFVX3lxTFBnYmhJVUZlX3kwY3ZyN1k4Sm56NEhaQ0JLMXJTSk94R05HeGhGLVh5Wm5DTFhiQUdLbDNyMVF3VXpidVFUekN1R2pLZ0ZEWGVEOTVoQ2Ntb05PNmNfNFdrVDVKdnN6dGFqUUE?oc=5" target="_blank">Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation</a>&nbsp;&nbsp;<font color="#6f6f6f">CTech</font>

Dec 17, 2025

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE9DZzlBMnhLSTZMbS1ieDd4V2Z6NU9UWHkwanJvX0lGN21VZGUzWDBic3BSS1lPazcxUkZ2UWdINndzQVJUQ2VtV2hOd1NaYnEtTFF5WmRSNWVkSmZXNy1vcHdselZqZkFP?oc=5" target="_blank">Secretive Israeli cyber startup Vega exits stealth with $65M at $400M valuation</a>&nbsp;&nbsp;<font color="#6f6f6f">CTech</font>

Sep 16, 2025

<a href="https://news.google.com/rss/articles/CBMia0FVX3lxTE1wcjUyODhWRGpNZ0ZGQW9LQmt2c2NOcjVNSDR2eVlJYzNWdXVwY3VUX1JaODdyUkZSMm1vaVlqSnBJeUZyRHU1dlZIczBRMlNSWlZuYjNmM0xDVDBpSUROZnphNElZRG5TVjNz?oc=5" target="_blank">The secretive Israeli cyber startup worth hundreds of millions—Vega Security raises $65M in stealth</a>&nbsp;&nbsp;<font color="#6f6f6f">CTech</font>

Mar 16, 2025